Today’s Top News ⇒ New Alzheimer’s Drug Slows Disease Progression by 35%

[Em Vicky Khan]

Pharmaceutical giant Eli Lilly announced successful Phase 3 trials for its new Alzheimer’s treatment “Reminexa,” which slows disease progression by up to 35% in early-stage patients. Experts are calling it the most promising advancement in two decades, with FDA fast-track approval expected this summer.

WHO Monitoring New COVID Subvariant ‘Omicron Pi’ – Here’s What You Need to Know
The World Health Organization is monitoring a new Omicron subvariant, unofficially named “Pi,” which has shown rapid transmission in parts of Asia and Europe. No major spike in hospitalizations yet, but booster campaigns are being launched as a precaution.